Samsara BioCapital is a venture capital firm. Based in Palo Alto, California, United States. The known portfolio counts 10 companies, including Parabilis Medicines, EpiBiologics, Ambrosia Biosciences, Sutro Biopharma, Kalaris Therapeutics and Sidewinder Therapeutics.
Is Samsara BioCapital a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Who to pitch at Samsara BioCapital
Samsara BioCapital portfolio companies (10)
- Parabilis Medicines
- EpiBiologics
- Ambrosia Biosciences
- Sutro Biopharma
- Kalaris Therapeutics
- Sidewinder Therapeutics
- Coultreon Biopharma
- Link Cell Therapies
- Primmune Therapeutics
- Psivant Therapeutics
Co-investors
Funds that share portfolio companies with Samsara BioCapital.
Similar funds
Showing 20 of 100
About Samsara BioCapital
The firm's listing covers sector Healthcare, and focus areas Biotech, Cell Therapy, Drug Discovery and Genomics; known deals cluster at Growth, Late-Stage and Series A.
The team counts 11 people in our database. Robert Baffi (President and Founder Baffi Biotech Advisors), Mike Dybbs (Partner) and Marcos Milla (Venture Partner) are shown as the contacts to pitch.
Samsara BioCapital shares portfolio companies with 20 other investment firms, among them Leerink Partners, ADAR1 Capital Management and Longwood Fund.
Frequently asked questions
What is Samsara BioCapital?
Samsara BioCapital is a venture capital firm based in Palo Alto, California, United States, with a known portfolio of 10 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What does Samsara BioCapital invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Cell Therapy, Drug Discovery and Genomics. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.
What stage does Samsara BioCapital invest at?
The known deals of Samsara BioCapital include Growth, Late-Stage and Series A rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.
Who should I pitch at Samsara BioCapital?
3 of the 11 people on file at Samsara BioCapital are listed as contacts for the firm. All 11 have their own profile page.
How do I contact Samsara BioCapital?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The 11 people attached to the firm have their own pages, each showing whether an address is on file for them.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal